XML 15 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Schedule of Segment Information) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Imprelis [Member]
Jun. 30, 2012
Imprelis [Member]
Jun. 30, 2012
Imprelis [Member]
Jun. 30, 2012
Agriculture [Member]
Jun. 30, 2011
Agriculture [Member]
Jun. 30, 2012
Agriculture [Member]
Jun. 30, 2011
Agriculture [Member]
Dec. 31, 2011
Agriculture [Member]
Jun. 30, 2012
Agriculture [Member]
Imprelis [Member]
Jun. 30, 2012
Agriculture [Member]
Imprelis [Member]
Jun. 30, 2012
Electronics and Communications [Member]
Jun. 30, 2011
Electronics and Communications [Member]
Jun. 30, 2012
Electronics and Communications [Member]
Jun. 30, 2011
Electronics and Communications [Member]
Jun. 30, 2012
Industrial Biosciences [Member]
Jun. 30, 2011
Industrial Biosciences [Member]
Jun. 30, 2012
Industrial Biosciences [Member]
Jun. 30, 2011
Industrial Biosciences [Member]
Jun. 30, 2012
Nutrition and Health [Member]
Jun. 30, 2011
Nutrition and Health [Member]
Jun. 30, 2012
Nutrition and Health [Member]
Jun. 30, 2011
Nutrition and Health [Member]
Jun. 30, 2012
Performance Chemicals [Member]
Jun. 30, 2011
Performance Chemicals [Member]
Jun. 30, 2012
Performance Chemicals [Member]
Jun. 30, 2011
Performance Chemicals [Member]
Jun. 30, 2012
Performance Coatings [Member]
Jun. 30, 2011
Performance Coatings [Member]
Jun. 30, 2012
Performance Coatings [Member]
Jun. 30, 2011
Performance Coatings [Member]
Jun. 30, 2012
Performance Materials [Member]
Jun. 30, 2011
Performance Materials [Member]
Jun. 30, 2012
Performance Materials [Member]
Jun. 30, 2011
Performance Materials [Member]
Jun. 30, 2012
Safety and Protection [Member]
Jun. 30, 2011
Safety and Protection [Member]
Jun. 30, 2012
Safety and Protection [Member]
Jun. 30, 2011
Safety and Protection [Member]
Jun. 30, 2012
Pharmaceuticals [Member]
Jun. 30, 2011
Pharmaceuticals [Member]
Jun. 30, 2012
Pharmaceuticals [Member]
Jun. 30, 2011
Pharmaceuticals [Member]
Jun. 30, 2012
Other [Member]
Jun. 30, 2011
Other [Member]
Jun. 30, 2012
Other [Member]
Jun. 30, 2011
Other [Member]
Jun. 30, 2012
Other [Member]
INVISTA [Member]
Jun. 30, 2012
Other [Member]
INVISTA [Member]
Segment sales $ 11,111 $ 10,368 $ 22,456 $ 20,505       $ 3,388 [1] $ 2,997 [1] $ 7,468 [1] $ 6,501 [1]       $ 795 $ 891 $ 1,472 $ 1,702 $ 300 $ 123 $ 588 $ 123 $ 885 $ 486 $ 1,693 $ 810 $ 1,968 $ 1,995 $ 3,868 $ 3,792 $ 1,089 $ 1,105 $ 2,139 $ 2,098 $ 1,699 $ 1,745 $ 3,299 $ 3,452 $ 986 $ 1,025 $ 1,927 $ 1,990 $ 0 $ 0 $ 0 $ 0 $ 1 $ 1 $ 2 $ 37    
Less: Transfers 105 104 220 207       2 [1] 0 [1] 4 [1] 0 [1]       5 5 9 10 2 1 5 1 0 0 0 0 69 69 146 136 0 0 0 0 24 26 50 54 3 3 6 6 0 0 0 0 0 0 0 0    
Net sales 11,006 10,264 22,236 20,298       3,386 [1] 2,997 [1] 7,464 [1] 6,501 [1]       790 886 1,463 1,692 298 122 583 122 885 486 1,693 810 1,899 1,926 3,722 3,656 1,089 1,105 2,139 2,098 1,675 1,719 3,249 3,398 983 1,022 1,921 1,984 0 0 0 0 1 1 2 37    
PTOI 1,898 1,943 4,225 4,068       661 [1],[2] 826 [1] 1,925 [1],[2] 1,937 [1]       197 [3] 103 230 [3] 214 44 (7) [4] 85 (7) [4] 112 5 [4] 195 30 [4] 538 503 1,050 897 92 73 179 138 317 254 557 542 127 143 227 288 16 80 43 130 (206) [5] (37) (266) [5] (101)    
Segment net assets               8,221   8,221   4,765                                                                                
Increase in net assets                   3,456                                                                                    
Product claims         (265) (315) (490)           (265) (315)                                                                            
Gain on sale of equity method investment 122 0 122 0                     122   122                                                                      
Charge related to litigation settlement                                                                                                     (137) (137)
Transaction related costs   $ (50)   $ (50)                               $ (17)   $ (17)   $ (33)   $ (33)                                                    
[1] As of June 30, 2012, Agriculture net assets were $8,221, an increase of $3,456 from $4,765 at December 31, 2011. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.
[2] Included charges of $(265) and $(315) during the three and six months ended June 30, 2012, respectively, recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 7 for additional information.
[3] Included a $122 gain recorded in other income, net related to the sale of the company's interest in an equity method investment.
[4] Included a $(50) charge for transaction related costs and the fair value step-up of inventories that were acquired as part of the Danisco acquisition in 2011, which impacted the segments as follows: Industrial Biosciences - $(17) and Nutrition & Health - $(33).
[5] Included a $(137) charge recorded in cost of goods sold and other operating charges primarily related to the company's settlement of litigation with INVISTA. See Note 7 for additional information.